Liabilities and Equity in USD of Cytek Biosciences, Inc. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Cytek Biosciences, Inc. quarterly Liabilities and Equity history and change rate from Q4 2020 to Q3 2025.
  • Cytek Biosciences, Inc. Liabilities and Equity for the quarter ending 30 Sep 2025 was $495M, a 0.75% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

Cytek Biosciences, Inc. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $495M +$3.69M +0.75% 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $493M +$9.6M +1.98% 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $483M -$9.47M -1.93% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $500M +$5.04M +1.02% 31 Dec 2024 10-Q 05 Nov 2025
Q3 2024 $491M -$28.2M -5.43% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $484M -$41.3M -7.87% 30 Jun 2024 10-Q 06 Aug 2024
Q1 2024 $492M -$32.5M -6.2% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 $494M -$25M -4.82% 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 $519M +$20.1M +4.03% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $525M +$32.2M +6.54% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $525M +$38.7M +7.96% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 $519M +$56.2M +12.1% 31 Dec 2022 10-K 13 Mar 2024
Q3 2022 $499M +$45M +9.9% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $493M +$263M +114% 30 Jun 2022 10-Q 10 Aug 2022
Q1 2022 $486M 31 Mar 2022 10-Q 12 May 2022
Q4 2021 $463M +$243M +111% 31 Dec 2021 10-K 01 Mar 2023
Q3 2021 $454M 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $230M 30 Jun 2021 10-Q 03 Sep 2021
Q4 2020 $220M 31 Dec 2020 10-K 17 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.